ArticleScience advances2026
In situ mechanostimulation of biohybrid millirobots for enhanced cell functionality and delivery.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study proposes a perforated, soft millirobot with dual functions: in situ mechanostimulation to enhance cell functionality and local cell delivery. Following protein modification and silica coating, the soft millirobots exhibit excellent biocompatibility, promoting cell adhesion and tissue ingrowth within their perforated architectures under both in vitro and in vivo conditions. They can apply in situ mechanostimulation to various cellular morphologies, including two-dimensional (2D) cell sheets, 3D cell-laden hydrogels, and ex vivo tissue models. The mechanical stimulation improves the functionality of muscle cells by enhancing cellular orientation, myotube contraction, and myocyte differentiation. In parallel, we develop an integrated robotic platform combining magnetic actuation with ultrasound imaging. It demonstrates the proof of principle that delivers 2D cell-sheet and 3D cell-laden biohybrid millirobots to narrow regions in an ex vivo pig liver model. This work expands the potential applications of soft millirobots in mechanobiology studies and future cell-based therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.